NO161220C - Analogifremgangsm te for fremstilling av terapeutisk aktivt 7-piperidin-1,2,3,5-tetrahydroimidazo-(2,1-b)-kinazolin-2-on. - Google Patents
Analogifremgangsm te for fremstilling av terapeutisk aktivt 7-piperidin-1,2,3,5-tetrahydroimidazo-(2,1-b)-kinazolin-2-on.Info
- Publication number
- NO161220C NO161220C NO842502A NO842502A NO161220C NO 161220 C NO161220 C NO 161220C NO 842502 A NO842502 A NO 842502A NO 842502 A NO842502 A NO 842502A NO 161220 C NO161220 C NO 161220C
- Authority
- NO
- Norway
- Prior art keywords
- tetrahydroimidazo
- kinazolin
- piperidin
- preparation
- therapeutic active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58111498A JPS604186A (ja) | 1983-06-21 | 1983-06-21 | イミダゾキナゾリン化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO842502L NO842502L (no) | 1984-12-27 |
| NO161220B NO161220B (no) | 1989-04-10 |
| NO161220C true NO161220C (no) | 1989-07-19 |
Family
ID=14562811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO842502A NO161220C (no) | 1983-06-21 | 1984-06-21 | Analogifremgangsm te for fremstilling av terapeutisk aktivt 7-piperidin-1,2,3,5-tetrahydroimidazo-(2,1-b)-kinazolin-2-on. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4596806A (ko) |
| EP (1) | EP0129258B1 (ko) |
| JP (1) | JPS604186A (ko) |
| KR (1) | KR910003153B1 (ko) |
| AT (1) | ATE29884T1 (ko) |
| AU (1) | AU558124B2 (ko) |
| CA (1) | CA1231946A (ko) |
| DE (1) | DE3466392D1 (ko) |
| DK (1) | DK162999C (ko) |
| ES (1) | ES533609A0 (ko) |
| FI (1) | FI77864C (ko) |
| GR (1) | GR81629B (ko) |
| IE (1) | IE57736B1 (ko) |
| IL (1) | IL72188A (ko) |
| NO (1) | NO161220C (ko) |
| PH (1) | PH19413A (ko) |
| PT (1) | PT78775A (ko) |
| YU (1) | YU43576B (ko) |
| ZA (1) | ZA844437B (ko) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4663320A (en) * | 1983-02-16 | 1987-05-05 | Syntex (U.S.A.) Inc. | (2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylamides, compositions and the use thereof |
| JPS6028979A (ja) * | 1983-07-14 | 1985-02-14 | Dai Ichi Seiyaku Co Ltd | イミダゾキナゾリン類化合物 |
| ZA851131B (en) * | 1984-02-15 | 1986-09-24 | Syntex Inc | (2-oxo-1,2,3,5-tetrahydroimidazo-(2,1-b)quinazolinyl)oxyalkylamides |
| US4783467A (en) * | 1985-06-05 | 1988-11-08 | Pfizer Inc. | Tetrahydroimidazoquinazolinone inotropic agents |
| US4837239A (en) * | 1985-08-23 | 1989-06-06 | Syntex (U.S.A.) Inc. | Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins |
| US4670434A (en) * | 1985-11-14 | 1987-06-02 | Syntex (U.S.A.) Inc. | (2-oxo-3-methylene-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolinyl)oxyalkylamides useful as cyclic AMP phosphodiesterase inhibitors |
| US4766126A (en) * | 1986-01-10 | 1988-08-23 | Daiichi Seiyaku Co., Ltd. | Process for treatment of nephritis with imidazoquinazolines |
| US4775674A (en) * | 1986-05-23 | 1988-10-04 | Bristol-Myers Company | Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors |
| US4701459A (en) * | 1986-07-08 | 1987-10-20 | Bristol-Myers Company | 7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation |
| US4761416A (en) * | 1986-07-25 | 1988-08-02 | Syntex (U.S.A.) Inc. | N-N-disubstituted-ω-[2-amino-3-(carbonylmethyl)-3, 4-dihydroquinazolinyl]oxyalkylamides and related compounds |
| US6818613B2 (en) * | 2001-11-07 | 2004-11-16 | Ortho-Mcneil Pharmaceutical, Inc. | Aqueous sustained-release formulations of proteins |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3932407A (en) * | 1973-11-19 | 1976-01-13 | Bristol-Myers Company | Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones |
| US3983120A (en) * | 1974-11-06 | 1976-09-28 | Bristol-Myers Company | Process for the preparation of optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones |
| US3983119A (en) * | 1974-11-06 | 1976-09-28 | Bristol-Myers Company | Process for the preparation of optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones |
| NL7807507A (nl) * | 1977-07-25 | 1979-01-29 | Hoffmann La Roche | Tricyclische verbindingen. |
| US4208521A (en) * | 1978-07-31 | 1980-06-17 | Bristol-Myers Company | Process for the preparation of imidazo[2,1-b]quinazolinones |
| US4455311A (en) * | 1981-08-28 | 1984-06-19 | Hoffmann-La Roche Inc. | Imidazoquinazoline derivatives which inhibit the aggregation of blood platelets, inhibit gastric secretion or have activity on the circulatory system |
-
1983
- 1983-06-21 JP JP58111498A patent/JPS604186A/ja active Granted
-
1984
- 1984-06-12 ZA ZA844437A patent/ZA844437B/xx unknown
- 1984-06-13 CA CA000456454A patent/CA1231946A/en not_active Expired
- 1984-06-13 DK DK290084A patent/DK162999C/da not_active IP Right Cessation
- 1984-06-15 AU AU29432/84A patent/AU558124B2/en not_active Ceased
- 1984-06-20 PT PT78775A patent/PT78775A/pt not_active IP Right Cessation
- 1984-06-20 EP EP84107130A patent/EP0129258B1/en not_active Expired
- 1984-06-20 IE IE1549/84A patent/IE57736B1/en not_active IP Right Cessation
- 1984-06-20 YU YU1078/84A patent/YU43576B/xx unknown
- 1984-06-20 AT AT84107130T patent/ATE29884T1/de active
- 1984-06-20 DE DE8484107130T patent/DE3466392D1/de not_active Expired
- 1984-06-20 PH PH30852A patent/PH19413A/en unknown
- 1984-06-20 ES ES533609A patent/ES533609A0/es active Granted
- 1984-06-20 US US06/622,596 patent/US4596806A/en not_active Expired - Fee Related
- 1984-06-21 GR GR75075A patent/GR81629B/el unknown
- 1984-06-21 NO NO842502A patent/NO161220C/no unknown
- 1984-06-21 IL IL72188A patent/IL72188A/xx unknown
- 1984-06-21 KR KR1019840003512A patent/KR910003153B1/ko not_active IP Right Cessation
- 1984-06-21 FI FI842532A patent/FI77864C/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FI842532A (fi) | 1984-12-22 |
| EP0129258A1 (en) | 1984-12-27 |
| ES8603483A1 (es) | 1985-12-16 |
| ZA844437B (en) | 1985-01-30 |
| PT78775A (en) | 1984-07-01 |
| AU558124B2 (en) | 1987-01-22 |
| GR81629B (ko) | 1984-12-11 |
| EP0129258B1 (en) | 1987-09-23 |
| FI842532A0 (fi) | 1984-06-21 |
| NO161220B (no) | 1989-04-10 |
| JPS635030B2 (ko) | 1988-02-01 |
| KR850000442A (ko) | 1985-02-27 |
| IE57736B1 (en) | 1993-03-24 |
| IE841549L (en) | 1984-12-21 |
| FI77864B (fi) | 1989-01-31 |
| DE3466392D1 (de) | 1987-10-29 |
| IL72188A (en) | 1987-03-31 |
| YU43576B (en) | 1989-08-31 |
| CA1231946A (en) | 1988-01-26 |
| US4596806A (en) | 1986-06-24 |
| DK162999C (da) | 1992-06-01 |
| YU107884A (en) | 1986-10-31 |
| FI77864C (fi) | 1989-05-10 |
| NO842502L (no) | 1984-12-27 |
| DK290084A (da) | 1984-12-22 |
| DK162999B (da) | 1992-01-06 |
| PH19413A (en) | 1986-04-10 |
| ATE29884T1 (de) | 1987-10-15 |
| AU2943284A (en) | 1985-01-03 |
| ES533609A0 (es) | 1985-12-16 |
| KR910003153B1 (ko) | 1991-05-20 |
| JPS604186A (ja) | 1985-01-10 |
| DK290084D0 (da) | 1984-06-13 |
| IL72188A0 (en) | 1984-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO163451C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminomethyloxooxazolidinylbenzenderivater. | |
| NO166639C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner. | |
| NO163406C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater. | |
| NO164165C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotetralinderivater. | |
| NO162238C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater. | |
| NO165239C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater. | |
| NO152129C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater | |
| NO166080C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner. | |
| NO161562C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater. | |
| NO164169C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzothiazinderivater. | |
| NO161220C (no) | Analogifremgangsm te for fremstilling av terapeutisk aktivt 7-piperidin-1,2,3,5-tetrahydroimidazo-(2,1-b)-kinazolin-2-on. | |
| NO164897C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater. | |
| NO161559C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater. | |
| NO158941C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater. | |
| NO160079C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater. | |
| NO165069C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere. | |
| NO158739C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater. | |
| NO160511C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater. | |
| NO162072C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyridinderivater. | |
| NO160139C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive akridanonderivater. | |
| NO162019C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidoiskinolinderivater. | |
| NO165295C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater. | |
| NO160141C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive kondenserte as-triazinderivater. | |
| NO161856C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3,4-diamino-1,2,5-tiadiazol-derivater. | |
| NO166715C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cytorodin s derivater. |